Form 4: DUKR Director Eran Antebi Granted Stock Options

DUKE Robotics Corp. Director Eran Antebi was granted options to purchase 4,000 shares of common stock at an exercise price of $7.88, vesting annually over three years.

Summary

• Eran Antebi, a Director of DUKE Robotics Corp. (DUKR), was granted options to purchase 4,000 shares of common stock.
• The options have an exercise price of $7.88 per share.
• The transaction date for this grant was March 10, 2026.
• The options will vest in three equal annual installments, with the first vesting date on March 10, 2027.
• The options have an expiration date of March 10, 2032.
• Following this transaction, Eran Antebi beneficially owns 4,000 derivative securities (options).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as the grant of stock options to a director aligns their incentives with shareholder value creation, fostering long-term commitment.

Positives

• The grant of stock options to a director, Eran Antebi, aligns management's interests with those of shareholders, incentivizing long-term company performance.
• The options have a six-year term until expiration (March 10, 2032), providing a substantial window for value creation.

Negatives

• No specific negative points are discernible from this routine insider transaction filing.

Future Outlook

The options granted to Director Eran Antebi are structured to vest in three equal annual installments starting March 10, 2027, indicating a long-term incentive structure tied to future company performance.

Industry Context

StockSavvy.ai notes that equity grants to directors, such as these stock options, are a common practice across industries to align the interests of board members with those of shareholders. This particular grant to a director at DUKE Robotics Corp. is consistent with standard corporate governance practices aimed at incentivizing long-term value creation.

Comparison to Industry Standards

• The grant of 4,000 options to a director is a relatively modest grant, common for non-executive directors in smaller to mid-cap companies. For example, similar grants are seen in technology firms like "Robotics Solutions Inc." or "Automation Dynamics LLC" for their independent directors, typically ranging from 2,000 to 10,000 options depending on company size and director responsibilities.
• An exercise price of $7.88, presumably the market price on the grant date, is standard practice for incentive stock options to ensure they are "at-the-money" at issuance.
• A three-year annual vesting schedule is a common industry standard for director equity awards, promoting retention and long-term commitment. Larger grants or executive awards might feature longer vesting periods or performance-based conditions.

Related Party Transactions

• The grant of stock options to Eran Antebi, a Director of DUKE Robotics Corp., constitutes a related party transaction as it involves an insider of the company.

Stakeholder Impact

• Shareholders: Potentially positive, as director incentives are aligned with long-term stock performance.
• Employees: No direct impact mentioned, but a well-incentivized board can lead to better company strategy, indirectly benefiting employees.

Next Steps

• The options will begin vesting in three equal annual installments starting March 10, 2027.
• The options will expire on March 10, 2032, if not exercised.

Key Dates

Keywords

DUKE Robotics Corp., DUKR, Eran Antebi, Stock Options, Insider Transaction, Form 4, Director Compensation, Equity Grant, Vesting Schedule